Andrica C. H. de Vries

Decreased serum anti-Mullerian hormone levels in girls with newly diagnosed cancer

Wendy van Dorp, Marry M. van den Heuvel‐Eibrink, Andrica C. H. de Vries et al. · Human Reproduction · 2013 · 68 citations · Full text

Medicine, Endocrinology, Oncology +10

Malignancy and mortality in paediatric‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric <scp>IBD</scp> Porto group of <scp>ESPGHAN</scp>

Maria E. Joosse, M Aardoom, Polychronis Kemos et al. · Alimentary Pharmacology & Therapeutics · 2018 · 53 citations · Full text

Medicine, Oncology, Pediatrics +12

Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study

Eva Clemens, Linda Broer, Thorsten Langer et al. · The Pharmacogenomics Journal · 2019 · 50 citations · Full text

Medicine, Otolaryngology, Pediatrics +17

A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy

Eva Clemens, Beth Brooks, Andrica C. H. de Vries et al. · PLoS ONE · 2019 · 44 citations · Full text

Medicine, Audiology, Oncology +17

Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study

Thorsten Langer, Eva Clemens, Linda Broer et al. · European Journal of Cancer · 2020 · 43 citations · Full text

Medicine, Genetics, Oncology +17